23andMe and Mirador Therapeutics Enter Into Strategic Research Collaboration to Advance Mirador’s Precision Medicines for Immunology & Inflammation
SUNNYVALE & SAN DIEGO, Calif., November 20, 2024 – [...]
Endpoints News Names Mirador Therapeutics a 2024 “Endpoints 11” Winner
Annual award recognizes the most promising biopharma startups SAN [...]
Mirador Therapeutics Appoints Gregg Gilbert as Chief Financial Officer
SAN DIEGO, September 17, 2024 –Mirador Therapeutics, Inc., a [...]
Mirador Therapeutics Launches to Accelerate the Next Generation of Precision Medicines for Immune-mediated Diseases
Rapidly advancing multiple therapeutic programs leveraging Mirador360 TM precision [...]